Prognostic factors in patients with advanced neuroendocrine neoplasia treated with radiopeptides (PRRT) - Data from the national registry SEPTRALU

被引：0
|
作者：
Bello, P. [1 ]
Mitjavila Casanovas, M. [2 ]
Jimenez-Fonseca, P. [3 ]
Cabezas Agricola, J. M. [4 ]
Hernando Cubero, J. [5 ]
Garcia Canamaque, L. [6 ]
Gajate, P. [7 ]
Riesco, M. C. [8 ]
Custodio, A. [1 ,9 ]
Miguel Martinez, M. B. [10 ]
Balaguer, D. [11 ]
Carmona-Bayonas, A. [12 ]
机构：
[1] Hosp Univ La Fe, Dept Nucl Med, Valencia, Spain
[2] Hosp Univ Puerta Hierro, Dept Nucl Med, Madrid, Spain
[3] Hosp Univ Cent Asturias, Dept Med Oncol, Oviedo, Spain
[4] Hosp Univ Santiago Compostela, Santiago De Compostela, Spain
[5] Hosp Univ Val dHebron, Barcelona, Spain
[6] Hosp HM Sanchinarro, Madrid, Spain
[7] Hosp Univ Ramon y Cajal, Madrid, Spain
[8] Hosp Univ Doce Octubre, Madrid, Spain
[9] Hosp Univ La Paz, Madrid, Spain
[10] Hosp Univ Burgos, Burgos, Spain
[11] Hosp Univ Doctor Peset, Valencia, Spain
[12] UMU, Hosp Univ Morales Meseguer, Hematol & Med Oncol Dept, IMIB, Murcia, Spain
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2023年 / 35卷
关键词：
177lu-dotatate; neuroendocrine tumor; prrt; prognosis; radionuclide therapy; survival;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H05
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [31] Prognostic factors in patients with advanced gastric cancer treated with cisplatin plus fluoropyrimidine
    Fukuda, Naoki
    Ohhara, Yoshihito
    Hirata, Yuya
    Yokoyama, Fumiaki
    Ishibashi, Yoko
    Sugai, Nozomu
    Seki, Hideyuki
    Fujita, Jun
    Suzuki, Junichi
    ANNALS OF ONCOLOGY, 2015, 26 : 133 - 133
  • [32] Prognostic factors of daily blood examination for advanced melanoma patients treated with nivolumab
    Okuhira, Hisako
    Yamamoto, Yuki
    Inaba, Yutaka
    Kunimoto, Kayo
    Mikita, Naoya
    Ikeda, Takaharu
    Kaminaka, Chikako
    Minami, Yoshimi
    Kanazawa, Nobuo
    Furukawa, Fukumi
    Jinnin, Masatoshi
    BIOSCIENCE TRENDS, 2018, 12 (04) : 412 - 418
  • [33] Comprehensive Analysis of Prognostic Factors in Advanced Gastric Cancer Patients Treated with Chemotherapy
    Cavdar, Eyyup
    Iriagac, Yakup
    Avci, Okan
    Seber, Erdogan Selcuk
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (11): : 1420 - 1424
  • [34] Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation
    Krishnan, Sunil
    Rana, Vishal
    Janjan, Nora A.
    Abbruzzese, James L.
    Gould, Morris S.
    Das, Prajnan
    Delclos, Marc E.
    Palla, Shana
    Guha, Sushovan
    Varadhachary, Gauri
    Evans, Douglas B.
    Wolff, Robert A.
    Crane, Christopher H.
    CANCER, 2006, 107 (11) : 2589 - 2596
  • [35] Prognostic factors for survival in patients with advanced gastric cancer treated with chemotherapy.
    Mangas, Montserrat
    Carmona Bayonas, Alberto
    Sanchez Lorenzo, Maria Luisa
    Ramchandani, Avinash
    Garcia, Teresa
    Custodio, Ana B.
    Lorenzo Barreto, Jose Enrique
    Diaz Guardamino, Isabel Echavarria
    Diaz Serrano, Asuncion
    Maria Cano, Juana
    Azkarate, Aitor
    Longo, Federico
    Mugica, Maitane
    Sanchez, Rodrigo
    Serrano, Raquel
    Alvarez Mancenido, Felipe Jose
    Alsina, Maria
    Jimenez-Fonseca, Paula
    Garrido, Marcelo
    Gallego Plazas, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [36] Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
    Fossa, SD
    Oliver, RTD
    Stenning, SP
    Horwich, A
    Wilkinson, P
    Read, G
    Mead, GM
    Roberts, JT
    Rustin, G
    Cullen, MH
    Kaye, SB
    Harland, SJ
    Cook, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (09) : 1380 - 1387
  • [37] Prognostic factors for survival in patients with advanced cholangiocarcinoma treated with percutaneous transhepatic drainage
    Rohan, Tomas
    Cechova, Barbora
    Matkulcik, Peter
    Straka, Matej
    Zavadil, Jan
    Eid, Michal
    Uher, Michal
    Dostal, Marek
    Andrasina, Tomas
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [38] Prognostic factors of recurrent respiratory papillomatosis from a registry of 72 patients
    Carvalho, Christine Martins
    Huot, Laure
    Charlois, Anne-Laure
    Khalfallah, Sonia Ayari
    Chapuis, Francois
    Froehlich, Patrick
    ACTA OTO-LARYNGOLOGICA, 2009, 129 (04) : 462 - 470
  • [39] Evaluating the prognostic significance of the pre-treatment neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios in 177Lu-DOTATATE PRRT treated patients with advanced metastatic neuroendocrine tumors
    Padwal, Mahesh K.
    Nazar, Amir K.
    Parghane, Rahul V.
    Basu, Sandip
    Basu, Bhakti
    ENDOCRINE, 2025,
  • [40] Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: A comparison with previously known prognostic models
    Baek, K.
    Kim, J.
    Um, J.
    Park, S.
    Lee, J.
    Park, J.
    Park, Y.
    Lim, H.
    Kang, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
12345